Harnessing the velocity of biopharmaceutical advances

Today’s pharmaphorum podcast addresses the subject of speed – the velocity at which biopharma is bringing new therapies and medicines to market faster.

CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.

Traditionally, liquid chromatography has been the go-to technique for sample separations, but its speed constraints have left researchers yearning for a faster alternative. Now, they are specifically looking for faster mass spectrometry instruments and advanced tools for sample preparation and separations – and that’s where 908 Devices comes in.

You can listen to episode 126a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, acast, Stitcher, and Podbean.